Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Yanjun Zhang , Gang Zeng , Hongxing Pan +17 more 2020 The Lancet Infectious Diseases 1488 citations